anti-CD38 monoclonal antibody SCTC21C

A monoclonal antibody that targets the cell surface glycoprotein CD38, with potential antineoplastic activity. Upon administration, anti-CD38 monoclonal antibody SCTC21C targets and binds to CD38 on CD38-positive tumor cells. This may kill, possiby through antibody-dependent cellular cytotoxicity (ADCC) or other responses, CD38-expressing tumor cells. CD38, a type II transmembrane glycoprotein, is present on various immune cells and hematologic malignancies.